GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's cash flow from others for the three months ended in Sep. 2016 was $-204 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2016 was $-1,210 Mil.
GlaxoSmithKline PLC Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2016 was -299.401197605 (Dec. 2015 ) + -326.210826211 (Mar. 2016 ) + -380.681818182 (Jun. 2016 ) + -203.679369251 (Sep. 2016 ) = $-1,210 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
GlaxoSmithKline PLC Annual Data
|Cash Flow from Others||1,361||808||945||3,343||1,436||3,299||-320||-207||-14,186||-1,186|
GlaxoSmithKline PLC Quarterly Data
|Cash Flow from Others||248||-133||-15,117||-953||-498||-299||-326||-381||-204||-372|